Compare · IRTC vs MDLN
IRTC vs MDLN
Side-by-side comparison of iRhythm Holdings Inc. (IRTC) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both IRTC and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $46.86B, about 11.5x IRTC ($4.06B).
- IRTC has been more active in the news (13 items in the past 4 weeks vs 12 for MDLN).
- Both have 25 recent analyst ratings on file.
- Company
- iRhythm Holdings Inc.
- Medline Inc.
- Price
- -
- -
- Market cap
- $4.06B
- $46.86B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2016
- 2025
- News (4w)
- 13
- 12
- Recent ratings
- 25
- 25
iRhythm Holdings Inc.
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. iRhythm Technologies, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
Latest IRTC
- iRhythm Holdings Inc. filed SEC Form 8-K: Leadership Update
- President and CEO Blackford Quentin S. was granted 48,534 shares and sold $3,348,012 worth of shares (26,859 units at $124.65), increasing direct ownership by 11% to 226,008 units (SEC Form 4) (for withholding tax)
- CBO and CLO Murphy Patrick Michael was granted 13,589 shares and sold $884,156 worth of shares (7,093 units at $124.65), increasing direct ownership by 10% to 69,699 units (SEC Form 4) to satisfy withholding tax
- EVP, Chief Risk Officer Shrishrimal Sumi was granted 9,706 shares and sold $669,641 worth of shares (5,372 units at $124.65), increasing direct ownership by 11% to 44,621 units (SEC Form 4) (withholding tax)
- CHIEF COMM & PRODUCT OFFICER Patterson Chad was granted 13,589 shares and sold $884,170 worth of shares (7,093 units at $124.65), increasing direct ownership by 12% to 62,125 units (SEC Form 4) (for withholding tax)
- CHIEF MED/SCI OFCR EVP ADVTECH Turakhia Minang sold $884,151 worth of shares (7,093 units at $124.65) and was granted 13,589 shares, increasing direct ownership by 12% to 60,116 units (SEC Form 4) to satisfy tax liability
- SEC Form 10-Q filed by iRhythm Holdings Inc.
- iRhythm Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- iRhythm Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- iRhythm to Acquire VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care
Latest MDLN
- SEC Form 4 filed by Chief Executive Officer Boyle James M
- SEC Form 4 filed by Chief Operating Officer Miller Stephen L
- Large owner Gic Private Ltd sold $57,280,000 worth of shares (1,600,000 units at $35.80) (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- Large owner Gic Private Ltd sold $21,002,305 worth of shares (590,284 units at $35.58) (SEC Form 4)
- Large owner Mozart Holdco, Inc. converted options into 500,000 shares and disposed of 500,000 units of Class B Common Stock, increasing direct ownership by 81,083% to 233,520,656 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- Large owner Gic Private Ltd sold $79,971,448 worth of shares (2,248,612 units at $35.56) (SEC Form 4)
- SEC Form SCHEDULE 13G filed by Medline Inc.
- SEC Form 10-Q filed by Medline Inc.